Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study.

Author: AparasuRajender R, ChenHua, HolmesHolly M, JohnsonMichael L, KachruNandita

Paper Details 
Original Abstract of the Article :
OBJECTIVES: This study examined the incidence and predictors of antimuscarinic medication use including non-selective antimuscarinics among older adults with dementia and overactive bladder (OAB). METHODS: The study used a new-user cohort design involving older adults (≥65 years) with dementia and ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/33890538

データ提供:米国国立医学図書館(NLM)

Antimuscarinics in Dementia: Navigating the Shifting Sands of Bladder Control and Cognitive Function

Dementia, a condition that affects millions worldwide, can be likened to a vast and shifting desert of cognitive decline. Navigating this landscape can be challenging for both patients and their caregivers, and managing overactive bladder (OAB) adds another layer of complexity. This study, based on Medicare data, delves into the use of antimuscarinic medications in older adults with dementia and OAB. The researchers analyzed data from over 3.3 million Medicare beneficiaries, revealing that a significant proportion of dementia patients experience OAB. They found that nearly one-third of dementia patients had OAB, and over one-fourth of these individuals were using antimuscarinics. The study explored factors influencing the use of these medications, revealing that demographic and clinical characteristics played a significant role. While certain demographics and clinical conditions were associated with a lower likelihood of initiating antimuscarinics, others were associated with an increased likelihood. This research emphasizes the importance of carefully considering both the benefits and risks of antimuscarinics in this patient population, highlighting the need for a nuanced approach to their use.

Antimuscarinics: A Careful Balancing Act in the Desert of Dementia

This study raises crucial considerations for the use of antimuscarinics in older adults with dementia and OAB. The findings underscore the need for a careful balancing act, weighing the benefits of improved bladder control against the potential for anticholinergic adverse effects. The study's identification of demographic and clinical factors influencing antimuscarinic use provides valuable insights for clinicians to tailor treatment approaches for this vulnerable population.

Living with Dementia: Navigating the Shifting Sands with Compassionate Care

This research highlights the importance of compassionate and informed care for individuals with dementia. It emphasizes the need for a careful assessment of individual needs and a thoughtful approach to medication management. The study's findings remind us that the desert of dementia is a challenging landscape, but with careful navigation and compassionate care, we can provide a supportive and dignified journey for those affected by this condition.

Dr.Camel's Conclusion

This research underscores the complexity of managing overactive bladder in dementia patients. The study highlights the need for a nuanced approach to antimuscarinic medication use, taking into account both the benefits and risks. By carefully considering these factors, clinicians can help navigate this complex terrain, improving the lives of individuals with dementia and OAB.

Date :
  1. Date Completed 2021-10-15
  2. Date Revised 2022-07-19
Further Info :

Pubmed ID

33890538

DOI: Digital Object Identifier

NIHMS1822272

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.